What is Morgans saying about Cochlear and Northern Star shares?

Here's what the broker is saying about these big names following their updates.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A couple of very popular ASX 200 shares have released updates this week and the team at Morgans has been digging into them.

Does the broker rate them as buys this week? Let's see what it is saying after running the rule over their updates:

A man rests his chin in his hands, pondering what is the answer?

Image source: Getty Images

Cochlear Ltd (ASX: COH)

This hearing solutions company's shares came crashing down to earth on Wednesday after making a major downgrade to its FY 2026 guidance.

While some of this downgrade has been driven by geopolitical impacts, the main driver was a surprising decline in demand in developed markets.

Morgans notes that this demonstrates that cochlear implant (CI) demand is more cyclical and macro-sensitive than previously assumed. As a result, it has put a hold rating on its shares with a heavily reduced price target of $107.17 (from $214.93). This compares to its current share price of $92.88. It said:

COH has delivered a material downgrade to FY26 earnings, cutting guidance by c30% at the midpoint. While FX, geopolitics and cost actions contributed, the key takeaway is more fundamental, with CI demand, especially in developed markets, proving to be more cyclical and macro-sensitive than previously assumed.

This challenges the market's long-held view as a structural, volume-driven growth story largely insulated from economic cycles. While we view long-term fundamentals as intact, near-term earnings visibility has deteriorated materially, so we wait for demand stabilisation before re-engaging. We adjust our FY26-28 estimates and lower our target price to A$107.17 HOLD.

Northern Star Resources Ltd (ASX: NST)

Another ASX 200 share that Morgans has been looking at is gold miner Northern Star.

It was pleased with the company's performance, noting that gold sold came in above its revised expectations thanks to improvements following production issues.

In addition, it notes that a $500 million buy back has been announced, that is commencing today.

In response to the update, the broker has retained its buy rating and $30.00 price target on Northern Star's shares. This implies potential upside of 33% for investors. It said:

Gold sold of 381koz at AISC of A$2,709/oz beat our revised expectations, with sequential improvement across all three production centres following ongoing production issues. KCGM Mill Expansion on track for commissioning in early FY27; FY26 guidance has been provided and is above 1,500koz at AISC of A$2,600–2,800/oz. Net cash of A$320m; A$500m on-market buy-back announced, commencing ~23 April. We maintain our BUY rating, price target A$30.00ps (unchanged).

Motley Fool contributor James Mickleboro has positions in Cochlear. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Broker Notes

Buy, hold, sell: NextDC, Hub24, PLS Group shares

The market is pessimistic about the next round of talks between the US and Iran.

Read more »

A team of people giving the thumbs up sign.
Broker Notes

5 ASX 200 shares with renewed buy ratings this week

Brokers have indicated continuing confidence in Cochlear, REA, and several other ASX 200 shares.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Broker reiterates buy ratings on 2 ASX shares

These ASX shares remain worth watching.

Read more »

Sell buy and hold on a digital screen with a man pointing at the sell square.
Broker Notes

After more than quadrupling investors' money in a year, are PLS shares still a buy?

A leading analyst delivers his outlook for the soaring PLS share price.

Read more »

A young man wearing a bright yellow jumper and glasses purses his lips together and moves them to the side of his face as he wonders about something.
Broker Notes

Buy, hold, or sell? Life360, Iress, Lynas Rare Earths shares

Experts reveal their views.

Read more »

Worried woman calculating domestic bills.
Broker Notes

Why did this broker just lower its outlook on this ASX 200 stock?

Despite a lowered outlook, attractive upside remains.

Read more »

Shocked office worker staring at computer screen with colleagues working in the background.
Broker Notes

Buy, hold, sell: Cleanaway, Hub24, and MAAS shares

Morgans has given its verdict on these shares. Is it bullish or bearish? Let's find out.

Read more »

Three excited business people cheer around a laptop in the office
Broker Notes

Missed out on Hub24 and Netwealth? Bell Potter thinks this ASX tech stock is next

This small-cap could have major upside potential according to the broker.

Read more »